2,155
Views
2
CrossRef citations to date
0
Altmetric
Articles

Assessment of environmental and occupational exposure while working with multidrug resistant (MDR) fungus Candida auris in an animal facility

, , , , , & show all

References

  • Jeffery-Smith, A., S.K. Taori, S. Schelenz, et al.: Candida auris: A review of the literature. Clin. Microbiol. Rev. 31(1)(2018).
  • Satoh, K., K. Makimura, Y. Hasumi, et al.: Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol. Immunol. 53(1): 41–44 (2009).
  • Sears, D., and B.S. Schwartz: Candida auris: An emerging multidrug-resistant pathogen. Int. J. Infect. Dis. 63:95–98 (2017).
  • Ku, T.S.N., C.J. Walraven, and S.A. Lee: Candida auris: Disinfectants and implications for infection control. Front Microbiol. 9:726 (2018).
  • Berkow, E.L., and S.R. Lockhart: Activity of novel antifungal compound APX001A against a large collection of Candida auris. J. Antimicrob. Chemother. 73(11):3060–3062 (2018).
  • Forsberg, K., K. Woodworth, M. Walters, et al.: Candida auris: The recent emergence of a multidrug-resistant fungal pathogen. Med. Mycol. 57(1):1–12 (2019).
  • Calvo, B., A.S. Melo, A. Perozo-Mena, et al.: First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia. J. Infect. 73(4):369–374 (2016).
  • Chowdhary, A., C. Sharma, S. Duggal, et al.: New clonal strain of Candida auris, Delhi, India. Emerg. Infect. Dis. 19(10):1670–1673 (2013).
  • Arauz, A.B., D.H. Caceres, E. Santiago, et al.: Isolation of Candida auris from 9 patients in Central America: Importance of accurate diagnosis and susceptibility testing. Mycoses. 61(1):44–47 (2018).
  • Control, C.D.C.: "General Information about Candida auris." Available at https://www.cdc.gov/fungal/candida-auris/candida-auris-qanda.html, 2019 (accessed December 1, 2018).
  • Forsberg, K., K. Woodworth, M. Walters, et al.: Candida auris: The recent emergence of a multidrug-resistant fungal pathogen. Med. Mycol. 57(1):1–12 (2019).
  • Lee, W.G., J.H. Shin, Y. Uh, et al.: First three reported cases of nosocomial fungemia caused by Candida auris. J. Clin. Microbiol. 49(9):3139–3142 (2011).
  • Magobo, R.E., C. Corcoran, S. Seetharam, and N.P. Govender: Candida auris-associated candidemia, South Africa. Emerg. Infect. Dis. 20(7):1250–1251 (2014).
  • Emara, M., S. Ahmad, Z. Khan, et al.: Candida auris candidemia in Kuwait, 2014. Emerg. Infect. Dis. 21(6):1091–1092 (2015).
  • Schelenz, S., F. Hagen, J.L. Rhodes, et al.: First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob. Resist. Infect. Control 5:35 (2016).
  • Vallabhaneni, S., A. Kallen, S. Tsay, et al.: Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus - United States, May 2013–August 2016. MMWR Morb. Mortal. Wkly. Rep. 65(44):1234–1237 (2016).
  • Ben-Ami, R., J. Berman, A. Novikov, et al.: Multidrug-resistant Candida haemulonii and C. auris, Tel Aviv, Israel. Emerg. Infect. Dis. 23(1)(2017).
  • Morales-Lopez, S.E., C.M. Parra-Giraldo, A. Ceballos-Garzon, et al.: Invasive infections with multidrug-resistant yeast Candida auris, Colombia. Emerg. Infect. Dis. 23(1):162–164 (2017).
  • Ruiz Gaitan, A.C., A. Moret, J.L. Lopez Hontangas, et al.: Nosocomial fungemia by Candida auris: First four reported cases in continental Europe. Rev. Iberoam. Micol. 34(1):23–27 (2017).
  • Wang, X., J. Bing, Q. Zheng, et al.: The first isolate of Candida auris in China: Clinical and biological aspects. Emerg. Microbes. Infect. 7(1):93 (2018).
  • Chowdhary, A., C. Sharma, and J.F. Meis: Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathog. 13(5):e1006290 (2017).
  • Durante, A.J., M.H. Maloney, V.H. Leung, J.H. Razeq, and D.B. Banach: Challenges in identifying Candida auris in hospital clinical laboratories: A need for hospital and public health laboratory collaboration in rapid identification of an emerging pathogen. Infect. Control. Hosp. Epidemiol. 39(8):1015–1016 (2018).
  • Piedrahita, C.T., J.L. Cadnum, A.L. Jencson, et al.: Environmental surfaces in healthcare facilities are a potential source for transmission of Candida auris and other Candida species. Infect. Control. Hosp. Epidemiol. 38(9):1107–1109 (2017).
  • Kathuria, S., P.K. Singh, C. Sharma, et al.: Multidrug-resistant Candida auris misidentified as Candida haemulonii: Characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and E-test method. J. Clin. Microbiol. 53(6):1823–1830 (2015).
  • Hager, C.L., E.L. Larkin, L. Long, et al.: In vitro and in vivo evaluation of the antifungal activity of APX001A/APX001 against Candida auris. Antimicrob. Agents Chemother. 62(3)(2018).
  • Larkin, E., C. Hager, J. Chandra, et al.: The emerging pathogen Candida auris: Growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob. Agents. Chemother. 61(5)(2017).
  • Hager, C.L., E.L. Larkin, L.A. Long, and M.A. Ghannoum: Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model. J. Antimicrob. Chemother. 73(8):2085–2088 (2018).
  • Lepak, A.J., M. Zhao, E.L. Berkow, S.R. Lockhart, and D.R. Andes: Pharmacodynamic optimization for treatment of invasive Candida auris infection. Antimicrob. Agents. Chemother. 61(8)(2017).
  • Leach, L., Y. Zhu, and S. Chaturvedi: Development and validation of a real-time PCR assay for rapid detection of Candida auris from surveillance samples. J. Clin. Microbiol. 56(2)(2018).
  • C.D.C.: "Environmental Disinfection." Available at https://www.cdc.gov/fungal/candida-auris/c-auris-infection-control.html#disinfection, (1 December 2018).
  • Cutler, J.E., M. Corti, P. Lambert, M. Ferris, and H. Xin: Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus. PLoS One. 6(7):e22030 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.